Addiction

Opioid pills

Health

With a new guide to tapering opioids, federal health officials seek a balanced approach to prescribing

By Andrew Joseph

Sesame Street addiction 02

Health

‘Sesame Street’ launches new initiative to help explain parental addiction to kids

By Shraddha Chakradhar

advertisement

Booneville, Kentucky

First Opinion

Beyond the Sacklers: Free-trade policies contributed to the opioid epidemic

By Adam Dean and Simeon Kimmel

advertisement

Purdue Pharma headquarters

Business

Purdue Pharma filed for bankruptcy. What does it mean for lawsuits against the opioid manufacturer?

By Andrew Joseph

Purdue Pharma headquarters

Business

Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy

By Andrew Joseph

TOBACCO TRIAL

Pharma

Historians push to create public archive of documents from massive opioid litigation

By Andrew Joseph

PHILLIP MORRIS HEADQUARTERS

First Opinion

Don’t let the opioid settlement fritter away funds like the tobacco settlement did

By Kathleen T. Brady

advertisement

Purdue Pharma headquarters

Pharma

OxyContin maker Purdue Pharma agrees to tentative settlement in opioid lawsuits

By Associated Press

advertisement

Purdue headquarters in shadow

Health

Purdue Pharma touts data that downplay its role in the opioid epidemic, new analysis shows

By David Armstrong and Jeff Ernsthausen — ProPublica

National Overdose Awareness Day

First Opinion

Removing the stigma of opioid addiction is a corporate responsibility

By Kate Cronin

Demonizing pain meds

First Opinion

Who is really behind a proposed new definition of pain?

By Dawn Rae Downton

Emergency room bays

First Opinion

Every hospital needs ‘recovery coaches’ for patients with substance use problems

By James Baird

The Readout LOUD

Listen: Purdue, J&J, and a week of big opioid crisis news

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

OxyContin

Health

Purdue Pharma, government attorneys in settlement talks

By Associated Press

Pharma

Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing

By David Armstrong — ProPublica

Opioid Lawsuit Oklahoma

Health

Oklahoma judge finds Johnson & Johnson fueled opioid crisis

By Associated Press

STAT Purdue illustration

First Opinion

Lost lives and long odds: Inside STAT’s decision to take on Purdue

purdue collage

Pharma

STAT wins long legal fight as Kentucky Supreme Court clears way for release of Purdue OxyContin files

By Andrew Joseph and Casey Ross

Alex Azar - July 2019

Politics

In bid to improve care, Trump administration to relax privacy rules for patients with history of addiction

Methadone clinic

Health

For the first time, U.S. panel recommends screening adults for illicit drug use

By Brittany Flaherty

narcan nasal spray (naloxone)

Health

For every 69 high-dose opioid prescriptions, U.S. pharmacies dispensed only one overdose-reversal drug

By Andrew Joseph

Maura Healey

Health

Purdue Pharma seeks to minimize its role in opioid crisis as it urges dismissal of Massachusetts suit

By Andrew Joseph

Deaths of despair

First Opinion

Rural Americans need help with ‘deaths of despair.’ Repealing the ACA won’t do that

By Nickolas D. Zaller

Oxycodone pain pills

Health

Study: 2% of women have ‘persistent’ opioid use after childbirth

By Lauren Joseph

Overdose response

First Opinion

Opioid overdose should be treated like attempted suicide: with an emergency hold

By David A. Patterson Silver Wolf

FDA; Drug Administration campus

Pharma

FDA, accused of being too lax in approval of opioids, outlines new criteria for future approvals

By Andrew Joseph

Flat tire

First Opinion

Hospitals are a missing link in easing the opioid crisis

By Richard Bottner and Christopher Moriates

Cigarette butts

First Opinion

Quitting smoking is hard. Mindfulness hacks the habit loop, offering a new approach

By Jud Brewer

Ryan Hampton

First Opinion

Why I believe the Warren-Cummings CARE Act can stop people like me from becoming opioid overdose statistics

By Ryan Hampton